Freedom Capital keeps Omnicell at Buy, cuts target to $55
Freedom Capital Markets kept its Buy rating on Omnicell shares and lowered the price target to $55 from $60, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Analysts at Freedom Capital Markets maintained their Buy rating on Omnicell and reduced the price target to $55 from $60, an 8.3% cut. TradingView reports this, citing reference data provided by Benzinga.
The new target implies an upside of 50.1% from the October 30 close of $36.65. The report also notes that it is not a personal recommendation and does not constitute investment advice.
why it matters
A single analyst changing a price target is a routine event for one stock, but it shows how professional market participants are revising their view of the company. Investors should compare such forecasts with earnings and share price trends rather than relying on them alone.
tags
instruments
sources
- Freedom Capital Markets maintains Omnicell at Buy, lowers price target to $55 from $60 — TradingView, 31 October 2026 at 01:06 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗